These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8988042)

  • 1. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents.
    Decaudin D; Geley S; Hirsch T; Castedo M; Marchetti P; Macho A; Kofler R; Kroemer G
    Cancer Res; 1997 Jan; 57(1):62-7. PubMed ID: 8988042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition.
    Zamzami N; Marzo I; Susin SA; Brenner C; Larochette N; Marchetti P; Reed J; Kofler R; Kroemer G
    Oncogene; 1998 Feb; 16(8):1055-63. PubMed ID: 9519879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H; Bouchon A; Stahl H; Krammer PH
    Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of Bcl-2 to block mitochondrial dysfunction during TRAIL-induced apoptosis. Tumor necrosis-related apoptosis-inducing ligand.
    Kim EJ; Suliman A; Lam A; Srivastava RK
    Int J Oncol; 2001 Jan; 18(1):187-94. PubMed ID: 11115558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
    Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S; Trauzold A; Boenicke L; Sandberg C; Beckmann S; Bayer E; Walczak H; Kalthoff H; Ungefroren H
    Oncogene; 2000 Nov; 19(48):5477-86. PubMed ID: 11114725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.
    Boehrer S; Chow KU; Beske F; Kukoc-Zivojnov N; Puccetti E; Ruthardt M; Baum C; Rangnekar VM; Hoelzer D; Mitrou PS; Weidmann E
    Cancer Res; 2002 Mar; 62(6):1768-75. PubMed ID: 11912153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus.
    Marchetti P; Zamzami N; Joseph B; Schraen-Maschke S; Méreau-Richard C; Costantini P; Métivier D; Susin SA; Kroemer G; Formstecher P
    Cancer Res; 1999 Dec; 59(24):6257-66. PubMed ID: 10626821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors.
    Shimizu S; Eguchi Y; Kamiike W; Waguri S; Uchiyama Y; Matsuda H; Tsujimoto Y
    Oncogene; 1996 Jul; 13(1):21-9. PubMed ID: 8700549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ornithine decarboxylase prevents tumor necrosis factor alpha-induced apoptosis by decreasing intracellular reactive oxygen species.
    Liu GY; Hung YC; Hsu PC; Liao YF; Chang WH; Tsay GJ; Hung HC
    Apoptosis; 2005 May; 10(3):569-81. PubMed ID: 15909119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
    Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
    Schmelz K; Wieder T; Tamm I; Müller A; Essmann F; Geilen CC; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2004 Sep; 23(40):6743-59. PubMed ID: 15273737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
    Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum localized Bcl-2 prevents apoptosis when redistribution of cytochrome c is a late event.
    Annis MG; Zamzami N; Zhu W; Penn LZ; Kroemer G; Leber B; Andrews DW
    Oncogene; 2001 Apr; 20(16):1939-52. PubMed ID: 11360178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyamine depletion induces apoptosis through mitochondria-mediated pathway.
    Nitta T; Igarashi K; Yamamoto N
    Exp Cell Res; 2002 May; 276(1):120-8. PubMed ID: 11978014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R
    Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.